2011
DOI: 10.1016/j.jri.2011.07.001
|View full text |Cite
|
Sign up to set email alerts
|

Intrauterine administration of autologous peripheral blood mononuclear cells increases clinical pregnancy rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
76
1
6

Year Published

2012
2012
2021
2021

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 72 publications
(87 citation statements)
references
References 23 publications
4
76
1
6
Order By: Relevance
“…Human peripheral blood HSC transplantation is now a well established curative treatment for patients with various hematologic malignancies [131], and techniques that exploit the multi-differentiation potential of PBMCs could lead to the isolation of cells for the treatment of presently incurable non-hematologic diseases as well [132-135]. However, many preclinical studies are still needed to better characterize the PBMC population and understand the biological mechanism of their multi-differentiation, and to further define their differentiation capacity, transplantability and biosafety.…”
Section: Resultsmentioning
confidence: 99%
“…Human peripheral blood HSC transplantation is now a well established curative treatment for patients with various hematologic malignancies [131], and techniques that exploit the multi-differentiation potential of PBMCs could lead to the isolation of cells for the treatment of presently incurable non-hematologic diseases as well [132-135]. However, many preclinical studies are still needed to better characterize the PBMC population and understand the biological mechanism of their multi-differentiation, and to further define their differentiation capacity, transplantability and biosafety.…”
Section: Resultsmentioning
confidence: 99%
“…The intrauterine administration of autologous PBMC, which was activated by incubation with hCG for 48 h, effectively improved the implantation, clinical pregnancy, and live birth rates of patients with repeated in vitro fertilization failure. Later, Okitsu et al [41] found that intrauterine administration of freshly isolated PBMC effectively improved embryo implantation in patients receiving frozen/thawed embryo transfer after three or more repeated in vitro fertilization failures. We previously proposed that the intrauterine administration of hCG-activated murine PBMC could promote embryonic implantation by regulating endometrial receptivity, providing a possible mechanism of this new immunotherapy [12].…”
Section: Discussionmentioning
confidence: 99%
“…PBMCs were found to produce cytokines and angiogenic factors necessary for implantation [56]. A study in humans has indicated that intrauterine infusion of PBMCs could help to improve the clinical pregnancy rate in patients with repeated implantation failure during in vitro fertilization-embryo transfer (IVF-ET) procedure [62], indicating that leucocytes play important role in ensuring the success of human embryo implantation.…”
Section: Lif Role In Leukocyte Recruitment During Implantationmentioning
confidence: 99%